Mirabegron for Treatment of Overactive Bladder Symptoms in Patients With Parkinson's Disease
Status:
Unknown status
Trial end date:
2018-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to see the study drug, Mirabegron, is safe and effective in
treating symptoms of Overactive Bladder in patients with Parkinson's disease.